# Final

## Continuous development
This guidance _should_ be continuously developed by all current and future adopters. Suggested changes should be reviewed and integrated acccording to the principles outlined in this guideline. 

Changes can be suggested at any time and will be immediately integrated after review by at least one member of each participating organisation.

The review considers that the proposed change _shall_ be:

1. Not in contradiction to a current policy or guideline that has been adopted by other laboratoes of the SEGLH.
2. Does not reduce interoperability capabilities of current processes.
3. Aiming to increase safety by reducing complexity or manual processes.
4. No impede or invalidate current established processes, unless those have been marked for retirement or replacement.
5. Not preventing the adoption of the guidance due to local incompatibilities.

This new version _can_ be adopted immediately. This allows individual laboratories or organisations to adapt quickly while wider adoption 

## Review and Revision
The guidance _shall_ be reviewed on an annual basis by the SEGLH Bioinformatics committee. The review should include the following:

1. Review of introduced changes.
2. Approval of new guidance.
3. Issue of new version number.
4. Report 

Any new versioned issue of this guidance _should_ be approved and adopted within 6 months.
